Relevance of Aortic Dissection Chronicity to the Development of Stent Graft-induced New Entry.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
12 2020
Historique:
received: 27 12 2019
revised: 24 03 2020
accepted: 03 04 2020
pubmed: 2 6 2020
medline: 30 12 2020
entrez: 2 6 2020
Statut: ppublish

Résumé

The relevance of aortic dissection chronicity to the development of stent graft-induced new entry (SINE) is unknown. This study enrolled 69 patients who underwent thoracic endovascular aortic repair (TEVAR) for chronic aortic dissection from January 2006 to December 2017 and were followed up for ≥6 months. Their medical records were reviewed retrospectively. Patients were stratified according to TEVAR timing into an early group (≤6 months from the onset of aortic dissection) and a late group (>6 months after the onset). The incidence of SINE as well as the interval between TEVAR and the development of SINE was compared between these groups. During the follow-up period, SINE occurred in 12% (3/26) and 35% (15/43) of patients in the early and late groups, respectively (P = .029). The interval between TEVAR and SINE development was significantly longer in the late group than the early group (median, 92 days vs 1144 days, respectively; P = .002). According to the multivariate analysis results, the late group (hazard ratio, 3.667; 95% confidence interval, 1.037-12.968; P = .044) and the distal oversizing ratio (hazard ratio, 1.492; 95% confidence interval, 1.071-2.080; P = .018) were the independent predictors for SINE development. TEVAR should be performed in the early period of the chronic phase to prevent SINE. Close and lifelong follow-up is mandatory for patients who undergo TEVAR >6 months after onset because SINE can develop several years after TEVAR in those patients.

Sections du résumé

BACKGROUND
The relevance of aortic dissection chronicity to the development of stent graft-induced new entry (SINE) is unknown.
METHODS
This study enrolled 69 patients who underwent thoracic endovascular aortic repair (TEVAR) for chronic aortic dissection from January 2006 to December 2017 and were followed up for ≥6 months. Their medical records were reviewed retrospectively. Patients were stratified according to TEVAR timing into an early group (≤6 months from the onset of aortic dissection) and a late group (>6 months after the onset). The incidence of SINE as well as the interval between TEVAR and the development of SINE was compared between these groups.
RESULTS
During the follow-up period, SINE occurred in 12% (3/26) and 35% (15/43) of patients in the early and late groups, respectively (P = .029). The interval between TEVAR and SINE development was significantly longer in the late group than the early group (median, 92 days vs 1144 days, respectively; P = .002). According to the multivariate analysis results, the late group (hazard ratio, 3.667; 95% confidence interval, 1.037-12.968; P = .044) and the distal oversizing ratio (hazard ratio, 1.492; 95% confidence interval, 1.071-2.080; P = .018) were the independent predictors for SINE development.
CONCLUSIONS
TEVAR should be performed in the early period of the chronic phase to prevent SINE. Close and lifelong follow-up is mandatory for patients who undergo TEVAR >6 months after onset because SINE can develop several years after TEVAR in those patients.

Identifiants

pubmed: 32479754
pii: S0003-4975(20)30762-1
doi: 10.1016/j.athoracsur.2020.04.032
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1983-1989

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Takafumi Ouchi (T)

Department of Radiology, Mie University Hospital, Tsu, Japan.

Noriyuki Kato (N)

Department of Radiology, Mie University Hospital, Tsu, Japan. Electronic address: nkato@clin.medic.mie-u.ac.jp.

Hiroaki Kato (H)

Department of Radiology, Mie University Hospital, Tsu, Japan.

Takatoshi Higashigawa (T)

Department of Radiology, Mie University Hospital, Tsu, Japan.

Hisato Ito (H)

Department of Thoracic and Cardiovascular Surgery, Mie University Hospital, Tsu, Japan.

Ken Nakajima (K)

Department of Radiology, Ise Red Cross Hospital, Ise, Japan.

Shuji Chino (S)

Department of Radiology, Ise Red Cross Hospital, Ise, Japan.

Toshiya Tokui (T)

Department of Thoracic Surgery, Ise Red Cross Hospital, Ise, Japan.

Toru Mizumoto (T)

Department of Cardiovascular Surgery, Anjo Kosei Hospital, Aichi, Japan.

Hajime Sakuma (H)

Department of Radiology, Mie University Hospital, Tsu, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH